BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8480488)

  • 1. In vivo evidence of all-trans retinoic acid inducing maturation in acute promyelocytic leukaemia.
    Hamidah HN; Cheong SK; Ainoon O
    Acta Haematol; 1993; 89(1):50-1. PubMed ID: 8480488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
    White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
    Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of extramedullary acute promyelocytic leukemia by all-trans-retinoic acid.
    Lederman CA; Weisberger J; Seiter K; Feldman EJ
    Leuk Lymphoma; 1995 Jun; 18(1-2):189-93. PubMed ID: 8580825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restitution of normal marrow morphology and karyotype in acute refractory acute promyelocytic leukaemia with all-trans retinoic acid.
    Creagh MD; Clark DJ; Collin RC
    Br J Haematol; 1991 Aug; 78(4):572. PubMed ID: 1911349
    [No Abstract]   [Full Text] [Related]  

  • 5. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M; Harrison K; Barton K; Nand S; Alkan S
    Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow necrosis following ALL-trans retinoic acid therapy for acute promyelocytic leukaemia.
    Dreosti LM; Bezwoda W; Gunter K
    Leuk Lymphoma; 1994 Apr; 13(3-4):353-6. PubMed ID: 8049655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone.
    Ohashi H; Ichikawa A; Takagi N; Hotta T; Naoe T; Ohno R; Saito H
    Leukemia; 1992 Aug; 6(8):859-62. PubMed ID: 1353552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
    N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
    Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
    Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute promyelocytic leukaemia relapsing after allogeneic bone marrow transplantation with all-trans-retinoic acid: suppression of the leukaemic clone.
    Bashford J; Szer J; Wiley JS; Buckley M; Garson OM; Van der Weyden MB
    Br J Haematol; 1991 Oct; 79(2):331-4. PubMed ID: 1958492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proposals for the objective indices for evaluating the differentiation of leukemic cells by all-trans retinoic acid in the patients with acute promyelocytic leukemia].
    Nakajima H; Kizaki M; Takayama N; Kawai Y; Watanabe K; Okamoto S; Ikeda Y
    Rinsho Ketsueki; 1996 Mar; 37(3):208-13. PubMed ID: 8727344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid.
    Wiernik PH; Dutcher JP; Paietta E; Hittelman WN; Vyas R; Strack M; Castaigne S; Degos L; Gallagher RE
    Leukemia; 1991 Jun; 5(6):504-9. PubMed ID: 2056773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system relapse in acute promyelocytic leukaemia treated with all-trans retinoic acid.
    Seldon M; Enno A
    Aust N Z J Med; 1998 Aug; 28(4):462. PubMed ID: 9777115
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous relapse in acute promyelocytic leukaemia following treatment with all-trans retinoic acid.
    Chang SE; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
    Br J Dermatol; 1999 Sep; 141(3):586-7. PubMed ID: 10583084
    [No Abstract]   [Full Text] [Related]  

  • 15. Dexamethasone does not counteract the response of acute promyelocytic leukaemia cells to all-trans retinoic acid.
    de Ridder MC; van der Plas AJ; Erpelinck-Verschueren CA; Löwenberg B; Jansen JH
    Br J Haematol; 1999 Jul; 106(1):107-10. PubMed ID: 10444171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation therapy in acute promyelocytic leukemia: European experience.
    Degos L
    J Cell Physiol; 1997 Nov; 173(2):285-7. PubMed ID: 9365538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All trans retinoic acid as a targeting drug for differentiation therapy in acute promyelocytic leukemia.
    Degos L
    Cancer Treat Res; 1993; 64():1-13. PubMed ID: 8095789
    [No Abstract]   [Full Text] [Related]  

  • 18. Approaches for an explanation of the differentiating effect of all trans retinoic acid in acute promyelocytic leukemia.
    Degos L
    Leukemia; 1992 Nov; 6 Suppl 4():44-6. PubMed ID: 1434831
    [No Abstract]   [Full Text] [Related]  

  • 19. All trans-retinoic acid in the treatment of promyelocytic leukaemia--a case report.
    Hoe TS; Cheong SK; Hussin NH; Chum KW
    Med J Malaysia; 1992 Sep; 47(3):225-7. PubMed ID: 1491649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic infiltration of the optic nerve treated by oral trans-retinoic acid.
    Brown DM; Kimura AE; Ossoinig KC; Weiner GJ
    Ophthalmology; 1992 Sep; 99(9):1463-7. PubMed ID: 1407980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.